Related Experiment Video
Updated: Jun 30, 2025

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
Published on: May 15, 2019
The Peptide Antibiotic Corramycin Adopts a β-Hairpin-like Structure and Is Inactivated by the Kinase ComG
Sebastian Adam1, Franziska Fries1,2,3, Alexander von Tesmar1
1Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Centre for Infection Research (HZI), Saarland University, Campus E8 1, 66123 Saarbrücken, Germany.
Abstract:
The rapid development of antibiotic resistance, especially among difficult-to-treat Gram-negative bacteria, is recognized as a serious and urgent threat to public health. The detection and characterization of novel resistance mechanisms are essential to better predict the spread and evolution of antibiotic resistance. Corramycin is a novel and modified peptidic antibiotic with activity against several Gram-negative pathogens. We demonstrate that the kinase ComG, part of the corramycin biosynthetic gene cluster, phosphorylates and thereby inactivates corramycin, leading to the resistance of the host. Remarkably, we found that the closest structural homologues of ComG are aminoglycoside phosphotransferases; however, ComG shows no activity toward this class of antibiotics. The crystal structure of ComG in complex with corramycin reveals that corramycin adopts a β-hairpin-like structure and allowed us to define the changes leading to a switch in substrate from sugar to peptide. Bioinformatic analyses suggest a limited occurrence of ComG-like proteins, which along with the absence of cross-resistance to clinically used drugs positions corramycin as an attractive antibiotic for further development.
Insights
A novel kinase, ComG, inactivates the antibiotic corramycin by phosphorylation, conferring host resistance. This discovery is crucial for developing new antibiotics against resistant Gram-negative bacteria.
Area of Science:
- Microbiology
- Biochemistry
- Structural Biology
Background:
- Antibiotic resistance in Gram-negative bacteria is a major public health threat.
- Understanding novel resistance mechanisms is key to combating resistance.
- Corramycin is a new peptide antibiotic effective against Gram-negative pathogens.
Purpose of the Study:
- To identify and characterize the mechanism of corramycin resistance.
- To elucidate the structure and function of the ComG kinase.
- To assess the potential of corramycin as a future antibiotic.
Main Methods:
- Biochemical assays to study kinase activity and substrate specificity.
- Crystallography to determine the structure of ComG in complex with corramycin.
- Bioinformatic analysis of ComG homologues.
Main Results:
- The kinase ComG inactivates corramycin via phosphorylation, conferring host resistance.
- ComG's closest structural relatives are aminoglycoside phosphotransferases, but ComG lacks activity against them.
- Structural analysis revealed corramycin's beta-hairpin structure and the basis for ComG's peptide substrate specificity.
Conclusions:
- ComG represents a novel mechanism of antibiotic resistance.
- Corramycin's unique resistance profile and ComG's specific activity suggest low cross-resistance potential.
- Corramycin is a promising candidate for further antibiotic development.
More Related Videos
12:03Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method
Published on: April 18, 2019
09:13Author Spotlight: Identifying Compensatory Pathways in Malaria Parasites Containing Hypomorphic Allele of Essential Protein Kinases
Published on: November 22, 2024
Related Concept Videos
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Anaphase Promoting Complex
Inhibition of Cdk Activity
Drugs that Destabilize Microtubules
The Electron Transport Chain
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...
GPCRs Regulate Adenylyl Cylase Activity